Full Press Release Details
Blog Post
| March 26, 2024
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Read More
Previous Article
Next Article
Blog Navigation
VANI Neutral Sentiment
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Key Takeaway: Vivani Medical has released a business update alongside its financial results for the fourth quarter and full year of 2023. The report includes key financial metrics and insights into the company's performance over the past year. Further details on specific business developments were not provided in the article.
Price reaction · baseline $1.92 (2024-03-25 close) · hit pre-market · clean, no other VANI news in the window
day 0 close
-2.1%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~10 mo
Medium dilution risk
Lead asset
Semaglutide
Phase 1 · Obesity & Overweight